Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized 13C-pyruvate Metabolic MRI in Prostate Cancer
NCT04698564Phase 2Terminated
- Sponsor
- University of Maryland, Baltimore
- Start
- Dec 2020
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyperpolarized 13C-pyruvate in prostate cancer (PCa), sponsored by University of Maryland, Baltimore. Started Dec 2020; status: terminated.
02
Drugs
hyperpolarized 13C-pyruvate
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04698564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04698564.